Channel Avatar

Novo Nordisk HCP Video Library @UCVZDe5-CjXU0khFjF0geO-g@youtube.com

12K subscribers - no pronouns :c

Specially created for HCPs practicing in the United States,


09:27
Tresiba® (insulin degludec) injection 100 U/mL, 200 U/mL Duration of Action With Dr Brunton
09:47
Why I Prescribe Tresiba® (insulin degludec) injection 100 U/mL, 200 U/mL For My Patients
10:36
How Tresiba® (insulin degludec) injection 100 U/mL, 200 U/mL Works With Dr Gavin
13:35
A Physician's Take On Tresiba® (insulin degludec) injection 100 U/mL, 200 U/mL FlexTouch®
10:28
Efficacy & Safety of Tresiba® (insulin degludec) injection 100 U/mL, 200 U/mL With Dr Edelman
09:04
Mechanism of Protraction for Tresiba® (insulin degludec) injection 100 U/mL, 200 U/mL
10:33
Tresiba® (insulin degludec) injection 100 U/mL, 200 U/mL Duration of Action With Dr Gavin
08:41
Tresiba® (insulin degludec) injection 200 U/mL: FlexTouch® U-200 Features
10:42
Tresiba® (insulin degludec) injection 100 U/mL: U-100 Overview & Coverage
13:43
Instructions For Using Tresiba® FlexTouch® U-100 (insulin degludec) injection
13:35
Instructions For Using Tresiba® FlexTouch® U-200 (insulin degludec) injection
12:36
GLP-1 RA: Rethinking the First Injectable for Patients
09:16
GLP-1 RA Expert Insights from Dr Richard Pratley Part 1
09:30
GLP-1 RA Expert Insights from Dr Richard Pratley Part 2
09:55
GLP-1 RA Expert Insights from Dr Richard Pratley Part 3
20:20
HCP Insights: Why I Prescribe a GLP-1 RA with Dr Carolina Solis-Herrera
23:36
HCP Insights: Approaches to Injectable Therapy with Dr James R. Gavin III
20:49
HCP Insights: How Patient Support Can Help in Treating Type 2 Diabetes with Dr Jennifer Goldman
01:52
My Approach to Treating Adult Patients with Type 2 Diabetes
01:13
The Importance of the ADA Treatment Guidelines for GLP-1 Receptor Agonists
06:32
Initiating Fiasp® (insulin aspart injection) 100 U/mL
09:20
Fiasp® (insulin aspart injection) 100 U/mL: A Team Approach
09:12
Why I Prescribe Fiasp® (insulin aspart injection) 100 U/mL For My Patients